CLINICAL_TRIALS
trial_result
· 2023-01-10
Clinical Trial Update: Efficacy, Tolerability, and Safety of DFN-15 [Phase 3]
Summary
Phase 3 trial updates report on efficacy, tolerability, and safety of DFN-15 for migraine, with completed status and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BioDelivery Sciences International | Conditions: Migraine Headache | Phase 3 | Status: COMPLETED | Results posted: 2023-01-10